4.6 Review

Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression

Journal

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Volume 21, Issue 1, Pages 19-25

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcdb.2009.10.002

Keywords

Carcinoma-associated fibroblasts (CAFs); Stromal myofibroblasts; Wound healing; Fibrosis TGF-beta; SDF-1

Funding

  1. Keio Gijuku Fukuzawa Memorial Fund
  2. Cancer Research UK (CR-UK) [C147/A6058]

Ask authors/readers for more resources

Tumours are highly complex tissues composed of carcinoma cells and surrounding stroma, which is constructed by various different types of mesenchymal cells and an extracellular matrix (ECM). Carcinoma-associated fibroblasts (CAFs), which consist of both fibroblasts and myofibroblasts, are frequently observed in the stroma of human carcinomas, and their presence in large numbers is often associated with the development of high-grade malignancies and poor prognoses. Moreover, in human tumour xenograft models, CAFs extracted from the tumour are more capable of promoting tumour growth through their interactions with carcinoma cells when compared to those isolated from non-cancerous stroma. Taken together, these observations strongly suggest that CAFs actively contribute to tumour progression. In this review we highlight the emerging roles of these cells in promoting tumourigenesis, and we discuss the molecular mechanisms underlying their tumour-promoting capabilities and their cellular origin. (C) 2009 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available